MétaCan
Menu
Back to cohort
Record W2909216997 · doi:10.1161/circgen.118.002335

Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition

2019· letter· en· W2909216997 on OpenAlexafffund
Ben Brumpton, Lars G. Fritsche, Jie Zheng, Jonas B. Nielsen, Maria Mannila, Ida Surakka, Humaira Rasheed, Gunnhild Åberge Vie, Sarah E. Graham, Maiken E. Gabrielsen, Lars Erik Laugsand, Pål Aukrust, Lars J. Vatten, Jan Kristian Damås, Thor Ueland, Imre Janszky, John‐Anker Zwart, Ferdinand M. van’t Hooft, Nabil G. Seidah, Kristian Hveem, Cristen J. Willer, George Davey Smith, Bjørn Olav Åsvold

Bibliographic record

VenueCirculation Genomic and Precision Medicine · 2019
Typeletter
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsInstitut de Readaptation Gingras Lindsay de Montreal
FundersNational Heart, Lung, and Blood InstituteMedical Research CouncilCanadian Institutes of Health Research
KeywordsPCSK9KexinProprotein convertaseSubtilisinMedicineInternal medicineEndocrinologyCholesterolLDL receptorChemistryLipoproteinBiochemistryEnzyme

Abstract

fetched live from OpenAlex

PCSK9 inhibitors have strong effects on lowering low-density lipoprotein cholesterol (LDL-C) and subsequent risk of cardiovascular disease. While a number of trials have evaluated the safety of such inhibitors in long-term clinical trials, a broad investigation of potential outcomes over the life-time, leveraging genetic variation in PCSK9 levels, has not been conducted. We aimed to investigate genetic variants associated with serum PCSK9 and the effect of LDL-C lowering variants on a range of potential outcomes. To achive this, we used data from the Nord-Trøndelag Health Study (HUNT)(n=69,424), a large population-based health study of the inhabitants of Nord-Trøndelag county, Norway. Firstly, we preformed a genome-wide association study of serum PCSK9 measured in 3697adults. Secondly we created a genetic risk score for PCSK9 as well as utilized existing scores for PCSK9 and HMGCR, and regressed these on a borad range of outcomes in the total sample. Thirdly, we perfomed two-sample medelian randomization on 50 outcomes using publically available datasets. Finally, we assessed the genetic correlation between PCSK9 and 229 diseases or traits using LD score regression. Three independent variants were GWAS significant (rs11591147, rs499883 and rs192265866). Using both existing genetic risk scores and scores defined from this discovery GWAS; we confirmed a strong association between serum PCSK9 and lower LDL-C and reducing risk of cardiovascular disease. We did not observe any consistently strong potentially adverse or beneficial associations. We observed some strong but not statistically significant genetic correlations between serum PCSK9 and fasting insulin, urate, uric acid and caudate volume. The lack of association between the genetic risk scores for PCSK9 and HMGCR is reassuring for the use of these treatments. However, further studies are warranted to confirm our findings, follow-up on the functional influences of the variants identified and extend our investigations to other outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.008
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0080.005
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.242
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueCirculation Genomic and Precision MedicineSame topicLipoproteins and Cardiovascular HealthFrench-language works237,207